● Recruiting

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

Condition: Carcinoma, Non-Small-Cell Lung · Sponsor: Janssen Research & Development, LLC

PhaseN/A

Planned participants380

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to describe the clinical and health-related outcomes of amivantamab-containing regimens for the treatment of common epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC; most common type of lung cancer) in a real-world setting. Metastatic NSCLC is when this disease spreads to other parts of body. NSCLC may occur due to mutations (changes) in many genes including epidermal growth factor receptor (EGFR).

This description comes directly from the study's public registry record.

Talk to the study team

Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com

Always discuss trial participation with your own doctor first.

Locations (75)

University Hospital Graz	Graz, Austria	Recruiting
Klinikum Klagenfurt am Worthersee	Klagenfurt, Austria	Recruiting
UZ Brussel	Brussels, Belgium	Recruiting
UZ Antwerpen	Edegem, Belgium	Recruiting
Jessa Ziekenhuis	Hasselt, Belgium	Recruiting
Az Groeninge	Kortrijk, Belgium	Recruiting
Chu Helora Hospital La Louviere Site Jolimont	La Louvière, Belgium	Recruiting
CHU de Liege	Liège, Belgium	Recruiting
Vitaz	Sint-Niklaas, Belgium	Recruiting
Fakultni nemocnice Brno	Brno, Czechia	Recruiting
Fakultni nemocnice Hradec Kralove	Hradec Králové, Czechia	Recruiting
Fakultni nemocnice Olomouc	Olomouc, Czechia	Recruiting

+ 63 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07230691